Avidity Biosciences, Inc. (RNA)

PetIQ Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	243.91	219.87	185.08	340.4	320.45	321.46
Short-Term Investments	939.24	1,282	410.27	270.33	85.1	6.68
Cash & Short-Term Investments	1,183	1,501	595.35	610.73	405.54	328.14
Cash Growth	-8.92%	152.20%	-2.52%	50.59%	23.59%	246.95%
Accounts Receivable	-	-	1.11	2.36	0.9	1.2
Other Receivables	8.54	28.22	7.52	1.51	-	-
Receivables	8.54	28.22	8.62	3.88	0.9	1.2
Prepaid Expenses	15.98	12.57	7.33	8.34	4.7	2.34
Total Current Assets	1,251	1,542	611.31	622.94	411.14	331.68
Property, Plant & Equipment	24.76	18.29	16.65	15.01	15.59	1.92
Other Long-Term Assets	93.6	3.32	0.6	0.85	0.85	0.3
Total Assets	1,369	1,564	628.56	638.8	427.58	333.9
Accounts Payable	3.91	8.46	8.81	4.64	2.81	7.75
Accrued Expenses	113.69	64.73	39.87	39.13	20.22	3.15
Current Portion of Leases	3.93	3.84	3.64	3.11	1.77	-
Current Unearned Revenue	13.54	20.99	28.37	5.04	4.86	3.69
Total Current Liabilities	135.06	98.02	80.68	51.91	29.66	14.59
Long-Term Leases	1.21	2.96	6.21	7.58	9.96	0.94
Long-Term Unearned Revenue	39.99	37.96	40.9	1.24	6.53	12.15
Total Liabilities	176.26	138.94	127.79	60.73	46.15	27.68
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	2,357	2,315	1,071	939.31	566.16	372.76
Retained Earnings	-1,166	-893.07	-570.76	-358.54	-184.55	-66.54
Comprehensive Income & Other	1.78	2.9	0.13	-2.7	-0.19	-0.01
Total Common Equity	1,193	1,425	500.76	578.08	381.43	306.22
Shareholders' Equity	1,193	1,425	500.76	578.08	381.43	306.22
Total Liabilities & Equity	1,369	1,564	628.56	638.8	427.58	333.9
Total Debt	5.14	6.8	9.85	10.69	11.73	0.94
Net Cash (Debt)	1,178	1,495	585.5	600.04	393.81	327.2
Net Cash Growth	-8.73%	155.29%	-2.42%	52.37%	20.36%	265.01%
Net Cash Per Share	9.22	13.40	8.02	11.50	9.51	15.10
Filing Date Shares Outstanding	128.65	120.21	79.72	70.81	47.75	37.58
Total Common Shares Outstanding	120.78	119.89	79.28	69.77	47.75	37.57
Working Capital	1,115	1,444	530.63	571.03	381.48	317.09
Book Value Per Share	9.87	11.89	6.32	8.29	7.99	8.15
Tangible Book Value	1,193	1,425	500.76	578.08	381.43	306.22
Tangible Book Value Per Share	9.87	11.89	6.32	8.29	7.99	8.15
Machinery	17.77	16.42	13.31	9.13	6.29	3.03
Construction In Progress	12.07	3.96	-	-	-	-
Leasehold Improvements	0.29	0.29	0.29	0.25	0.25	0.42

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q